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A snake venom group IIA PLA2 
with immunomodulatory activity 
induces formation of lipid 
droplets containing 15-d-PGJ2 in 
macrophages
Karina Cristina Giannotti1, Elbio Leiguez1, Ana Eduarda Zulim de Carvalho1, Neide Galvão 
Nascimento1, Márcio Hideki Matsubara1, Consuelo Latorre Fortes-Dias  2, Vanessa Moreira3 & 
Catarina Teixeira1
Crotoxin B (CB) is a catalytically active group IIA sPLA2 from Crotalus durissus terrificus snake venom. 
In contrast to most GIIA sPLA2s, CB exhibits anti-inflammatory effects, including the ability to inhibit 
leukocyte functions. Lipid droplets (LDs) are lipid-rich organelles associated with inflammation 
and recognized as a site for the synthesis of inflammatory lipid mediators. Here, the ability of CB to 
induce formation of LDs and the mechanisms involved in this effect were investigated in isolated 
macrophages. The profile of CB-induced 15-d-PGJ2 (15-Deoxy-Delta-12,14-prostaglandin J2) production 
and involvement of LDs in 15-d-PGJ2 biosynthesis were also investigated. Stimulation of murine 
macrophages with CB induced increased number of LDs and release of 15-d-PGJ2. LDs induced by CB 
were associated to PLIN2 recruitment and expression and required activation of PKC, PI3K, MEK1/2, 
JNK, iPLA2 and PLD. Both 15-d-PGJ2 and COX-1 were found in CB-induced LDs indicating that LDs 
contribute to the inhibitory effects of CB by acting as platform for synthesis of 15-d-PGJ2, a pro-
resolving lipid mediator. Together, our data indicate that an immunomodulatory GIIA sPLA2 can directly 
induce LD formation and production of a pro-resolving mediator in an inflammatory cell and afford new 
insights into the roles of LDs in resolution of inflammatory processes.
Phospholipases A2 (PLA2s) are enzymes that play a key role in a range of cellular processes in physiological and 
pathological conditions by regulating the release of arachidonic acid (AA), a precursor of distinct classes of lipid 
mediators such as prostaglandins and leukotrienes, which are key regulators of inflammatory processes1. These 
enzymes have been classified into fifteen groups (I–XV) and subgroups according to nucleotide and amino acid 
sequence criteria. The groups comprise five distinct types of enzymes: secreted (sPLA2), cytosolic (cPLA2) and cal-
cium independent (iPLA2) PLA2s, platelet activating factor (PAF) acetylhydrolases and lysosomal PLA2s2. Group 
IIA includes mammalian inflammatory sPLA2s and phospolipases present in viperid snake venoms3. Crotoxin B 
(CB), a group IIA sPLA2 isolated from Crotalus durissus terrificus (Cdt) snake venom, is one of the two subunits 
that form crotoxin, the major component of Cdt venom. In contrast to most group IIA sPLA2s, CB per se displays 
immunomodulatory effects4, 5. It is able to inhibit macrophage spreading and phagocytic activities, both of which 
are associated with increased levels of lipoxin A4 (LXA4), an important arachidonic acid-derived lipid mediator 
shown to be active in the resolution phase of inflammation6. CB also induces the biosynthesis and release of 
prostaglandin E2 (PGE2) and D2 (PGD2) via activation of the catalytic activity of cyclooxygenase-1 (COX-1)7. 
Although PGE2 is known to dilate blood vessels, potentiating edema formation, its immunosuppressive activi-
ties, including inhibition of the phagocytic functions and microbicidal activity of macrophages, have been well 
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demonstrated8–10. Similarly, while PGD2 is an important mediator of the acute inflammatory response, its hydrol-
ysis product, 15-deoxy12–14 PGJ2 (15-d-PGJ2), is a major mediator during the resolution phase of inflammation, 
regulating the switch from acute inflammation to active inflammatory resolution11, 12. Despite the importance of 
15-d-PGJ2 as a pro-resolving mediator, there is currently no information in the literature about its production by 
innate immune cells stimulated by group IIA PLA2s, including CB.
Under inflammatory and infectious conditions, prostaglandins and other lipid mediators can be synthesized 
by cytoplasmic organelles known as lipid droplets (LDs), which are lipid-rich structures composed of a neu-
tral lipid core surrounded by a monolayer of phospholipids13. These organelles compartmentalize key enzymes 
involved in the synthesis of lipid mediators, such as COX-1, COX-2 and 5-lypoxigenase, as well as proteins related 
to membrane trafficking, cell signaling, such as kinases, and structural proteins, such as perilipin 2 (PLIN2)14–17, 
an important protein involved in LD assembly, adipocyte differentiation and foam cell formation18–20. LDs have 
been shown to play central roles in the heightened production of lipid mediators, which in turn drive the evolu-
tion of the inflammatory response21, 22. Indeed, increased numbers of LDs have been observed in leukocytes in a 
number of clinical and experimentally induced inflammatory diseases23, 24.
Recently, the inflammatory group IIA sPLA2s have emerged as critical regulators of LD formation, as they 
provide free fatty acids from membrane phospholipids that are crucial for this process, directly regulating assem-
bly of these organelles25. In light of this and the fact that CB, a group IIA sPLA2, is able to release arachidonic 
acid7, a major fatty acid involved in both LD formation and lipid-mediator production26, 27 during inflammatory 
processes, we decided to investigate the ability of CB to induce LD formation and the mechanisms involved in 
LD formation, as well as 15-d-PGJ2 production, in macrophages. We also investigated the involvement of LDs in 
CB-induced 15-d-PGJ2 biosynthesis as well as the involvement of COX-1, COX-2, cPLA2, iPLA2 and the signaling 
pathway proteins PI3K, PKC, MEK1/2 and JNK in LD formation.
Materials and Methods
Reagents and chemicals. Hema-3 stain was purchased from Biochemical Sciences Inc. (Swedesboro, 
NJ, USA). Brewer thioglycolate medium was purchased from Difco, Surrey, UK and RPMI 1640 from Thermo 
Scientific, Waltham, MA, USA. MTT and L-glutamine were purchased from USB Corporation (Cleveland, OH, 
USA). H7, SB202190, PD98059, JNK inhibitor II and Pyr-2 were purchased from Calbiochem-Novabiochem 
Corp. (La Jolla, CA, USA), and racemic BEL, FKGK11, CAL-101, ERK inhibitor, HQL-79 and Valeryl Salicylate 
from Cayman Chemical (Ann Arbor, MI, USA). SB203580, GF109203X and SP600125X were purchased from 
Sigma-Aldrich Corporation (St. Louis, MO, USA). U0126, phospho and total-PKC, -PI3K, -MEK1/2 and -JNK 
were obtained from Cell Signaling Technology Inc. (Danvers, MA, USA). SC-560 was a kindly supplied by Dr. 
Alexandre A. Steiner – Dept. of Immunology, ICB, Sao Paulo University, Brazil. Horseradish peroxidase con-
jugated goat anti-rabbit IgG antibody, mouse monoclonal anti-β-actin antibody and Nile Red were purchased 
from Sigma-Aldrich Corporation (St. Louis, MO, USA). Guinea pig polyclonal anti-mouse PLIN2 antibody and 
FITC-conjugated donkey anti-guinea pig antibody were purchased from Research Diagnostics Inc. (Flanders, 
NJ, USA). Secondary anti-mouse and anti-guinea pig horseradish peroxidase conjugated antibodies and nitro-
cellulose membrane were purchased from GE Healthcare (Buckinghamshire, UK). Gentamicin was purchased 
from Schering-Plough Corporation (Kenilworth, NJ, USA). DMSO and BSA were purchased from Amresco Inc. 
(Cleveland, OH, USA). RPMI-1640, thiocarbohydrazide, OsO4, N-ethyl-N′-(3-dimethylaminopropyl) carbod-
iimide hydrochloride (EDAC) and RIPA Buffer (lysis buffer) were purchased from Sigma-Aldrich (Swedesboro, 
NJ, USA). All the salts used were purchased from Merck KgaA (Darmstadt, Germany). Paraformaldehyde was 
purchased from Electron Microscopy Sciences (Hatfield, PA, USA). Alexa Fluor 488 goat anti-mouse IgG was 
purchased from Life Technologies Corporation (Carlsbad, CA, USA) and prostaglandin E2, prostaglandin J2 
and cyclooxigenase-1 monoclonal antibodies from Cayman Chemical (Ann Arbor, MI, USA). Fluoromount-G 
was purchased from Molecular Probes (Eugene, OR, USA). Donkey serum was purchased from Jackson 
ImmunoResearch Laboratories, Inc. (West Grove, PA, USA), Triton-X from Union Carbide Corporation 
(Houston, TX, USA).
Animals. Male Swiss mice (18–20 g) from the Butantan Institute (Sao Paulo, Brazil) were used. The ani-
mals were housed in a temperature-controlled room (22–24 °C) with a 12 h light-dark cycle and received fresh 
water and food ad libitum until they were used. The study was approved by the Butantan Institute Animal 
Experimentation Ethics Committee (reference no. 846/11) in accordance with the procedures laid down by the 
Universities Federation for Animal Welfare.
Phospholipase A2. CB-sPLA2 was obtained from crotoxin (CTX) isolated from Cdt snake venom by 
reversed-phase chromatography27, 28, using a 201SP54 column (Grace Vydac, CA, USA). Briefly, 1 mg of CTX 
was loaded onto the column, and fractions of 0.2 mL were eluted with a linear gradient of 0.1% trifluoroacetic 
acid (TFA) in H2O and 0.1% TFA in acetonitrile. CTX was isolated from Cdt venom by conventional gel filtra-
tion on Sephadex 7529. CB identity was checked by SDS-polyacrylamide gel electrophoresis under non-reducing 
conditions and by matrix-assisted laser desorption ionization time-of-flight mass spectrometry in an AutoFlex 
III MALDI-TOF-TOF instrument (Bruker Daltonics, Bremen, Germany). The PLA2 activity of CB was assayed 
using the classical egg yolk clearing method30. The absence of endotoxin contamination in the CB preparation 
was demonstrated by the quantitative Limulus Amebocyte Lysate (LAL) test31, which revealed undetectable levels 
of endotoxin (<0.125 EU/mL).
Macrophage harvesting. Elicited macrophages were harvested four days after i.p. injection of 1 mL of 3% 
Brewer thioglycolate medium. The animals were killed under CO2 atmosphere, and the cells were harvested by 
washing the peritoneal cavities with 3 mL of PBS, pH 7.2, containing 10 IU/mL heparin. Aliquots of the washes 
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were used for total cell counts in a Neubauer chamber after dilution (1:20, v/v) in Turk’s solution (0.2% crystal 
violet dissolved in 30% acetic acid). Differential cell counts were performed on smears stained with Hema-3 and 
examined under light microscopy. More than 95% of the cell population consisted of macrophages according to 
conventional morphological criteria. The remaining peritoneal wash was centrifuged at 500 g for 6 min (4 °C), and 
the cell pellets were used for subsequent studies after suitable dilutions.
Cytotoxicity assay. Cytotoxicity of CB and all the pharmacological agents used toward thioglycolate-elicited 
macrophages was evaluated using a tetrazolium-based assay (MTT). In brief, 2 × 105 macrophages/well in RPMI-
1640 medium supplemented with 40 µg/mL gentamicin sulfate and 2 mM L-glutamine were plated in 96-well 
plates and incubated with 100 μL of selected concentrations of CB (0.1–0.8 μM) diluted in medium or with the 
same volume of medium alone (control) for 1, 3, 6, 12 or 24 h at 37 °C in a humidified atmosphere of 5% CO2. 
MTT (5 mg/mL) was dissolved in PBS and filtered to sterilize it and remove a small amount of insoluble residue 
present in some batches. Stock MTT solution (10% in culture medium) was added to all wells in each assay, and 
the plates were incubated at 37 °C for 3 h. Next, a volume of 100 μL of DMSO was added to the wells and mixed 
thoroughly at room temperature for 30 min. Absorbance at 540 nm was then recorded in a microtiter plate reader. 
Results were expressed as percentage of viable cells, and the control cells (incubated with medium alone) were 
considered 100% viable.
Macrophage culture and stimulation. Macrophages were plated on glass coverslips in 24-well plates 
at a density of 2 × 105 cells/coverslip and allowed to attach for 30 min at 37 °C under a 5% CO2 atmosphere. 
Non-adherent cells were removed by washing with PBS. Cell monolayers were cultured for 1 h in RPMI-1640 
supplemented with 40 μg/mL gentamicin sulfate and 2 mM L-glutamine at 37 °C and 5% CO2 and were then 
challenged with selected concentrations of CB (0.1–0.8 μM) or culture medium alone (control). Where appro-
priate, the following inhibitors were used: 6 μM H7 or 1 μM GF109203X, both inhibitors of PKC (protein kinase 
C); 1 μM LY294002 or 1 μM CAL-101, both inhibitors of PI3K (phosphoinositide 3-kinase); 1 μM U73122, an 
inhibitor of PLC (phospholipase C); 1 μM FIPI, an inhibitor of PLD (phospholipase D); 2 μM JNK inhibitor II 
or 10 μM SP600125, both inhibitors of JNK (c-Jun N-terminal kinase); 25 μM U0126, an inhibitor of MEK1/2; 
5 μM SB202190 or 16 μM SB203580, inhibitors of p38MAPK (mitogen-activated protein kinase); 25 μM PD98059 
or 5 μM ERK inhibitor, both inhibitors of ERK1/2; 1 μM Pyr-2 (Pyrrolidine-2), an inhibitor of cPLA2; 2 μM BEL 
(bromoenol lactone) or 1μM FKGK11, both inhibitors of iPLA2, 30 μM HQL-79, an inhibitor of PGD synthase 
and 450 μM valeryl salicylate or 0.5 μM SC-560, both inhibitors of COX-1. All the stock solutions were prepared 
in DMSO and stored at −20 °C. Aliquots were diluted in RPMI-1640 immediately before use to give the required 
concentration. The final DMSO concentration was always lower than 1% and had no effect on the number of 
LDs. Pharmacological inhibitors were added 30 or 60 min before stimulation of macrophages with CB or culture 
medium (control) at concentrations previously tested32–44. Cells treated with the inhibitors were analyzed for 
viability with the MTT assay. No significant changes in cell viability were registered with any of the above agents 
or the vehicle at the concentrations used (data not shown).
Lipid droplet staining and quantification. Analysis of LD numbers was performed in osmium-stained 
cells. In brief, macrophages (2 × 105 cells) adhered to glass coverslips were fixed in 4% paraformaldehyde (PFA) 
in 0.1 M phosphate buffer, pH 7.2, for 15 min and stained with OsO4 (osmium tetroxide). The coverslips were 
then rinsed in 0.1 M phosphate buffer, stained in 1% OsO4 (30 min), rinsed in deionized H2O, immersed in 1.0% 
thiocarbohydrazide (5 min), rinsed again in 0.1 M phosphate buffer, re-stained with 1% OsO4 (3 min), rinsed 
with H2O and then dried and mounted. The morphology of the fixed cells was examined, and round osmiophilic 
structures were identified as LDs, which were then counted under phase-contrast microscopy using a 100x objec-
tive lens in 50 consecutively scanned macrophages in each coverslip. For assays with fluorescent-labeled LDs, 
macrophages (2 × 105 cells) adhered to glass coverslips were incubated with Nile Red staining solution freshly 
prepared in 0.1 M phosphate buffer (10 μg/mL) for 20 min at room temperature and washed with phosphate 
buffer. After several washes the coverslips were mounted with Fluoromount-G and examined under a confocal 
microscope (Zeiss LSM 510 Meta confocal microscope).
Immunocytochemistry analysis. Detection of PLIN2 in CB-stimulated macrophages was performed by 
PLIN2 immunostaining. Cells were fixed in 2% PFA, permeabilized with 0.2% Triton-X 100 in 0.1 M phosphate 
buffer and blocked with 0.5% normal donkey serum in 0.1 M phosphate buffer for 90 min. After PBS washes, 
macrophages were incubated for 1 h with guinea pig polyclonal anti-mouse PLIN2 (1:2000) diluted in 0.1 M phos-
phate buffer with 0.2% Triton-X 100. After three washes with PBS (10 min each), the preparations were incubated 
with secondary FITC-conjugated donkey anti-guinea pig antibody (1:500) in the dark for 1 h. After the washes, 
the slides were mounted with Fluoromount-G and examined under a confocal laser scanning microscope (Zeiss 
LSM 510 Meta). For analysis of COX-1and 15-d-PGJ2 immunostaining, the cells were fixed and permeabilized 
in 1% EDAC45 in calcium- and magnesium-free Hank balanced salt solution (HBSS−/−). The macrophages were 
blocked with 0.5% normal donkey serum in 0.1 M phosphate buffer for 60 min and then washed with HBSS−/− 
and incubated for 1 h with monoclonal antibodies against COX-1 or 15-d-PGJ2 (1:100). After further washes, the 
cells were incubated with goat anti-mouse Alexa Fluor 488 or goat anti-rabbit Alexa Fluor 488 (1:250) and Nile 
Red solution (1:250) for 1 h. The coverslips were then washed three times and mounted with Fluoromount-G and 
examined under a confocal laser scanning microscope (Zeiss LSM 510 Meta).
Western blotting. For PLIN2 detection, whole cells extracts obtained by lysing the pellets with 100 μL 
of sample buffer (0.5 M Tris–HCl, pH 6.8, 20% SDS, 1% glycerol, 1 M β-mercaptoethanol, 0.1% bromophenol 
blue) and boiling them for 10 min were used. Samples were resolved by SDS polyacrylamide gel electrophore-
sis (SDS-PAGE) on a 10% bis-acrylamide gel overlaid with a 5% stacking gel. Proteins were then transferred 
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to a nitrocellulose membrane (GE Healthcare, Buckinghamshire, UK) using a Mini Trans-Blot® (Bio-Rad 
Laboratories, Richmond, CA, USA). The membranes were blocked for 1 h with 5% nonfat dry milk in TTBS 
(20 mM Tris, 100 mM NaCl and 0.5% Tween 20) and incubated with a primary antibody against PLIN2 (Abcam) 
overnight at 4 °C or with β-actin (Sigma) for 1 h at room temperature. They were then washed and incubated 
with the appropriate horseradish peroxidase conjugated anti-rabbit IgG secondary antibody (1:1000 dilution, 1 h, 
room temperature). To analyze phosphorylated forms of PI3K, MEK1/2, ERK1/2 and JNK, the cells were lysed 
using RIPA® (Sigma Aldrich) with a protease inhibitor cocktail and phosphatase inhibitors (sodium fluorate 
10 mM and sodium orthovanadate 1 mM) and then dissolved (1:5 v/v) in the sample buffer and boiled for 10 min. 
After the proteins had been separated by SDS-PAGE (12%) and transferred to a nitrocellulose membrane, as 
described above, the phosphorylated and total non-phosphorylated proteins were detected using polyclonal anti-
bodies to PI3K, MEK1/2, ERK1/2 and JNK (1:1000) and total kinases (1:650) overnight at 4 °C, followed by incu-
bation with horseradish peroxidase-conjugated anti-rabbit IgG (1:1000, 1 h, room temperature). Detection was by 
the enhanced chemiluminescence (ECL) method according to the manufacturer’s instructions (GE Healthcare, 
Buckinghamshire, UK). Band densities were quantified with a GS 800 Densitometer (Bio-Rad Laboratories, 
Richmond, CA) using Molecular Analyst® image analysis software (Bio-Rad Laboratories, Richmond, CA).
Quantification of 15-d-PGJ2 concentrations. 15-d-PGJ2 (15-deoxy12–14 PGJ2) concentrations were 
determined by a specific enzyme immunoassay using a commercial kit (Enzo life Sciences, Inc. New York, USA) 
as per manufacturer’s protocol.
Statistical Analysis. Data are expressed as the mean ± standard error of mean (SEM) of at least three inde-
pendent experiments. Multiple comparisons among groups were performed with one-way ANOVA followed by 
Tukey’s test. Probabilities of less than 5% (p < 0.05) were considered statistically significant.
Results
CB induces LDs formation in macrophages. To investigate whether CB would induce formation of 
LDs in isolated macrophages, these cells were incubated for 1 h with CB at non cytotoxic concentrations ranging 
from 0.1 to 0.8 µM. Lack of cytotoxicity with these concentrations of CB was previously determined (1–24 h 
time intervals) by MTT assay. As shown in Fig. 1A, incubation of macrophages for 1 h with CB at concentrations 
ranging from 0.2 to 0.8 µM, but not 0.1 µM, induced a significant increase in the number of LDs compared with 
control cells incubated with culture medium alone. Maximal LD numbers were observed with a concentration of 
0.8 µM. This CB-induced effect was not observed in Ca2+-free, EGTA-containing medium, in a medium in which 
Ca2+ had been replaced by Sr2+ or when CB was inactivated by p-bromophenacyl bromide (p-BPB) (Fig. 1B), 
indicating that the catalytic activity of this sPLA2 is essential for induction of LD formation under the present 
experimental conditions. To determine the time-course of CB-induced LD formation, a submaximal concen-
tration of this sPLA2 was used (0.4 µM), and the number of LDs after 1–24 h of incubation was determined. As 
shown in Fig. 1, CB caused a significant increase in the number of LDs after 1–24 h incubation compared with 
control cells. The greatest number of LDs was detected after 12 h of incubation (Fig. 1C). As illustrated in Fig. 1D, 
control macrophages stained with OsO4 showed very few inclusions in the cytoplasm. In contrast, the cytoplasm 
in CB-stimulated macrophages was packed with the osmiophilic organelles, which can be seen as dark punctate 
structures in Fig. 1E, F and G. Taken together, these findings indicate that CB is able to induce LD biogenesis in 
cultured macrophages in a rapid-onset effect that is dependent on the incubation time and catalytic activity of 
this enzyme.
CB induces protein expression of PLIN2 and its recruitment to LDs in macrophages. PLIN2 
is a fatty acid-binding protein that plays an important role in LD assembly and the development of foamy mac-
rophages18. In an attempt to better understand the stimulatory effect of CB that leads to LD formation in mac-
rophages, we investigated whether CB induces expression of PLIN2. While this revealed increased levels of PLIN2 
expression in cell extracts stimulated with CB for 1, 3 and 12 h, but not for 6 and 24 h, extracts from unstimulated 
cells (controls) failed to show significant levels of PLIN2 for any of the incubation periods tested (Fig. 2A, B and 
Supplementary Fig. S1). These findings demonstrate that CB is able to up-regulate PLIN2 expression at transla-
tional levels and suggest a mechanism for the increase in LB formation detected in CB-stimulated macrophages. 
Considering that the increase of PLIN2 protein expression occurred since the first hour of stimulation by CB it is 
possible that the amount of PLIN2 needed to supply the increased assembly of LDs induced by CB was enough at 
6 h of stimulation leading to the transient lack of increase of PLIN2 protein expression seen at 6 h of stimulation 
by this sPLA2. At 24 h, however, the absence of PLIN2 protein expression was accompanied by a significant decay 
of LD numbers, suggesting that CB-induced effect falls into decline. To further identify the mechanisms involved 
in CB-induced LD formation, the ability of CB to recruit PLIN2 into cytosol LDs was investigated. As illustrated 
in Fig. 2C, macrophages stimulated with CB (0.4 µM) for 3 h exhibited strong fluorescent staining (green) for 
PLIN2 with a punctate cytoplasmic pattern that was absent in the unstimulated control cells. Fluorescent Nile 
Red-labeled neutral lipid inclusions (LDs) overlapping with stained cytoplasmic PLIN2 were also visualized 3 h 
after CB-induced stimulation indicating that PLIN2 co-localizes to LDs. As expected, no significant staining was 
detected in control macrophages. These data demonstrate the ability of CB to recruit PLIN2 from cell membranes 
to form new LDs in macrophages.
Distinct signaling pathways are involved in CB-induced LD formation. Regulation of LD forma-
tion induced by diverse inflammatory agents involves stimulus-specific signaling pathways46. Participation of 
protein kinases in the signaling triggered by sPLA2s has been previously reported47, 48. Therefore, the critical 
signaling proteins involved in CB-induced LD biogenesis were investigated using pharmacological approaches. 
The effects of selected pharmacological treatments were evaluated 3 h after incubation of macrophages with CB. 
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To investigate the role of PKC and PI3K in CB-induced LD formation, macrophages were treated with selective 
PKC and PI3K inhibitors (H7, GF109203X and LY294002, CAL101, respectively) or their vehicles (controls) prior 
to incubation with CB, followed by quantification of osmium-stained LDs. As seen in Fig. 3A and B, both PKC 
inhibitors (H7 and GF109203X) and PI3K inhibitors (LY294002 and CAL101) abolished the increased LD forma-
tion in CB-stimulated macrophages compared with vehicle-treated CB-stimulated macrophages. Next, we inves-
tigated whether the effect of CB on LD formation is related to MAPKs p38MAPK, ERK1/2 or JNK. As demonstrated 
in Fig. 3C and D, neither ERK1/2 inhibitors (PD98059 and ERK inhibitor), nor p38MAPK inhibitors (SB202190 
and SB203580) changed the number of LDs in CB-stimulated macrophages compared with vehicle-treated mac-
rophages stimulated with CB. Furthermore, Fig. 3E shows that pharmacological inhibition of cells with JNK 
inhibitors (JNK inhibitor II and SP600125) abrogated LD formation in CB-stimulated macrophages compared 
with untreated control cells. The next protein evaluated was MEK1/2, an important upstream protein of the 
MAPK signaling pathway. U0126, a MEK1/2 inhibitor, reduced the increase in LD formation in CB-stimulated 
macrophages compared with vehicle-treated control cells (Fig. 3E), reinforcing the role of the MAPK family in 
CB-induced LD formation in macrophages. Activation of the proteins PKC, PI3K, MEK1/2 and JNK was con-
firmed by evaluating the extent of phosphorylation (Fig. 4A, B, C and D). CB induced a significant increase in 
phosphorylation of these proteins only at the 5-minute time point.
Figure 1. CB induces LD formation in peritoneal macrophages. (A) Effect of CB on LD formation in 
macrophages incubated with selected concentrations of CB or with RPMI (control) for 1 h. (B) Effect of 
catalytically active CB on LD formation in peritoneal macrophages incubated with one of the following for 
1 h: (i) CB (0.4 μM) in a medium containing EGTA (200 μM) with or without Ca2+; (ii) CB (0.4 μM) in a 
medium in which Ca2+ was replaced by Sr2+; or (iii) RPMI alone (control) (C) Time-course of CB-induced LD 
formation. Macrophages were incubated with CB (0.4 µM) or RPMI (control) for 1, 3, 6, 12 or 24 h. LDs were 
quantified using light microscopy after OsO4 staining. (D) Osmium-stained LDs observed in control cells or 
in cells stimulated with CB (0.4 µM) for 1 h (E), 6 h (F) or 12 h (G). Each bar represents the mean ± SEM of the 
number of LDs/cell in 50 cells. Values represent mean ± SEM for three to five animals. *p < 0.05 compared with 
RPMI-stimulated cells; &p < 0.05 compared with cells stimulated with CB for 1 h, #p < 0.05 compared with cells 
stimulated with CB for 1, 3 and 6 h, °p < 0.05 compared with cells stimulated with CB for 12 h, and +p < 0.05 
compared with CB/Ca2+-stimulated cells.
www.nature.com/scientificreports/
6Scientific RepoRts | 7: 4098  | DOI:10.1038/s41598-017-04498-8
PLD and iPLA2 are involved in CB-induced LD formation in macrophages. It has been reported 
that phospholipase D (PLD) and phospholipase C (PLC) play important roles in the signal transduction pathways 
associated with LD formation49. As seen in Fig. 5A, pre-treatment of macrophages with U73122, an inhibitor of 
PLC, did not have an effect on CB-induced LD formation in comparison with control cells. However, when the 
cells were incubated with compound FIPI, an inhibitor of PLD (Fig. 5B), LD formation induced by CB was abro-
gated compared with controls. These results indicate that PLD is critical for the stimulatory effect of CB on LDs 
formation in macrophages, whereas PLC does not contribute to this CB-induced effect. Additionally, it is known 
that the intracellular PLA2s, such as calcium independent PLA2 (iPLA2) and cytosolic PLA2 (cPLA2) have a role 
in LDs formation47, 50. Moreover, a cross talk between sPLA2s and intracellular PLA2s for production of prosta-
glandins and LDs has been described7, 47. Therefore, to verify whether iPLA2 and/or cPLA2 would be committed 
to CB-induced LD formation, macrophages were treated with low micromolar concentrations of Pyr-2, a specific 
inhibitor of cPLA2α, or with either BEL or FKGK11, both inhibitors of iPLA2. As shown in Fig. 5C, treatment 
of macrophages with BEL or FKGK11, but not Pyr-2, caused a significant reduction in the number of LDs in 
CB-stimulated macrophages compared with CB-stimulated vehicle-treated cells. These data indicate that iPLA2, 
but not cPLA2 plays a role in LD formation induced by CB in macrophages.
CB induces production of 15-d-PGJ2 via COX-1 in macrophages. 15-d-PGJ2, which is a 
PGD2-derived prostanoid51, has been described as a pro-resolving lipid mediator, which is involved in the switch 
Figure 2. CB up- regulates PLIN2 protein expression in macrophages. Peritoneal macrophages were incubated 
with CB (0.4 µM) or RPMI (control) for 1, 3, 6, 12 and 24 h. (A) Western blotting of PLIN2 and β-actin 
(loading control) in macrophage extracts. Immunoreactive bands of 24 h were obtained in a distinct assay. 
(B) Densitometric analysis of PLIN2 bands. The densities (in arbitrary units) were normalized with those of 
β-actin. Results are expressed as mean ± SEM for three experiments. *p < 0.05 compared with RPMI. Blots 
were cropped and full-length blots can be found as Supplementary Figure S1. (C) Macrophages were incubated 
with RPMI (control) or CB (0.4 µM) for 3 h and labeled for LDs (with Nile Red) and for PLIN2 (with FITC-
conjugated antibody). The merged image shows colocalization of PLIN2 to LDs. The pictures are representative 
of three independent experiments.
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from the acute into the regenerative phases of inflammation52. We have previously reported that CB elicits pro-
duction of high levels of PGD2 by isolated macrophages7. On this basis, we evaluated the ability of CB to induce 
the release of 15-d-PGJ2 from macrophages in culture. 15-d-PGJ2 concentration was measured in supernatants 
from macrophages incubated with either a sub-cytotoxic concentration of CB (0.4 μM) or RPMI alone (con-
trol). As shown in Fig. 6A, incubation of macrophages with CB induced a significant increase in 15-d-PGJ2 con-
centration in the supernatants from 1 up to 24 h, with levels ranging from 1545 ± 149.5 to 2283 ± 340.5 pg/mL 
(p < 0.05). The corresponding control values ranged from 110.1 ± 11.5 to 1333 ± 179.3 pg/mL. These results are 
evidence of the ability of CB to induce generation of 15-d-PGJ2. Considering that (i) cyclooxygenases are key 
enzymes in the prostaglandin biosynthetic pathway and (ii) previous data from our group showing that COX-1, 
Figure 3. Signaling pathways involved in CB-induced LD formation in macrophages. Macrophages were 
incubated with one of the following inhibitors before stimulation with CB (0.4 µM) for 3 h: (A) PKC inhibitors 
H7 (6 µM) or GF109203X (1 μM) for 1 h, (B) PI3K inhibitors LY294002 (1 µM) or CAL101 (1 µM) for 1 h; (C) 
p38MAPK SB inhibitors SB201290 (5 µM) or SB203580 (16 µM); (D) ERK1/2 inhibitors PD98059 (25 µM) or ERK 
inhibitor (5 µM) for 1 h; (E) MEK1/2 inhibitor, U0126 (25 µM) or JNK inhibitors JNK inhibitor II (2 μM) or 
SP600125 (10 µM) for 1 h. LDs were counted using light microscopy after osmium staining. Each bar represents 
the mean ± SEM of the number of LDs/cell in 50 cells. Values represent means ± SEM for three to five animals. 
*p < 0.05 compared with RPMI/vehicle-stimulated cells; #p < 0.05 compared with vehicle treated/CB-stimulated 
cells.
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but not COX-2 is activated by CB in macrophages7, the effect of inhibitors of COX-1 on CB-induced biosynthesis 
of 15-d-PGJ2 was examined. As demonstrated in Fig. 6B, 1 h pretreatment of macrophages cultures with valeryl 
salicylate (450 μM) or SC-560 (0.5 μM), both specific COX-1 inhibitors, abolished 15-d-PGJ2 release induced 
by CB after 3 h and 12 h of incubation in comparison with control cells, pretreated with vehicle and stimulated 
with CB, indicating participation of COX-1 isoform in the synthesis of 15-d-PGJ2 induced by CB. In addition, 
we evaluated the participation of PGD synthase coupled to COX-1 in CB-induced 15-d-PGJ2 release. As shown 
in same Fig. (6B), 1 h pretreatment of macrophages cultures with HQ compound (30 μM), a prostaglandin D 
synthase (PGDS) inhibitor, abolished 15-d-PGJ2 release induced by CB at 3 and 12 h of incubation in comparison 
with control cells, pretreated with vehicle and stimulated with CB, confirming the role of PGD2 as the precursor 
of 15-d-PGJ2 in the present experimental condition.
Cytoplasmic LDs in CB-stimulated macrophages compartimentalize 15-d-PGJ2 and COX-1 
and drive 15-d-PGJ2 production. LDs are known to be organelles associated with the synthesis and stor-
age of inflammatory mediators in immunocompetent cells, such as macrophages. In order to investigate the 
Figure 4. CB induces PKC, PI3K, MEK1/2 and JNK activation in isolated macrophages. Macrophages were 
incubated with CB (0.4 μM) or RPMI (control) for 1 or 5 min. Western blotting of total and phospho-PKC (A), 
total and phospho- PI3K (B), total and phospho-MEK1/2 (C), total and phospho-JNK (D) and β-actin (loading 
control) in macrophage extracts. Densitometric analysis of the phosphorylated protein bands (E, F, G and H). 
The densities (in arbitrary units) were normalized with those of β-actin. Results are expressed as mean ± SEM 
for three experiments. *p < 0.05 compared with RPMI-stimulated cells.
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possible role of CB-induced LDs as intracellular sites for the synthesis of lipid mediators, specially 15-d-PGJ2, 
macrophages stimulated or not by CB were incubated with EDAC to immobilize the newly synthesized eicosa-
noids45 and immunostained with antibodies against 15-d-PGJ2 and against COX-1, and LDs were stained with 
Nile Red. As illustrated in Fig. 7A, macrophages stimulated with CB (0.4 µM) for 3 h exhibited a (green) cyto-
plasmic staining pattern for 15-d-PGJ2. This pattern was not observed in the unstimulated control cells, which 
exhibited diffuse staining. Fluorescent Nile Red-labeled LDs were also visualized 3 h after stimulation by CB 
and were virtually absent in unstimulated control macrophages. Overlapping images show that stained cytoplas-
mic 15-d-PGJ2 matched perfectly with neutral lipid inclusions in CB-stimulated macrophages indicating that 
15-d-PGJ2 co-localizes to LDs. In light of our present results showing that formation of LDs induced by CB was 
inhibited by PKC and JNK, the role of LDs in the synthesis of 15-d-PGJ2 induced by CB was further investigated 
pretreating macrophages with either PKC inhibitors (H7 and GF109203X) or JNK inhibitors (JNK inhibitor II 
and SP600125), which abolished CB-induced LD formation, or their vehicles (controls) prior to incubation with 
CB for 3 h, followed by quantification of 15-d-PGJ2 levels in cell supernatants. As seen in Fig. 7B, treatment of 
cells with PKC inhibitors abolished the increased 15-d-PGJ2 production in CB-stimulated macrophages com-
pared with vehicle-treated CB-stimulated macrophages. Moreover, Fig. 7C demonstrates that pharmacological 
inhibition of cells with JNK inhibitors abrogated 15-d-PGJ2 production in CB-stimulated macrophages compared 
with untreated control cells. In addition, as illustrated in Fig. 8A, macrophages stimulated with CB (0.4 µM) 
for 3 h exhibited a punctate cytoplasmic fluorescence (green) for COX-1. This pattern could not be observed 
in the unstimulated control cells, in which diffuse staining was observed. Fluorescent Nile Red-labeled LDs 
were also visualized 3 h after stimulation by CB and were virtually absent in unstimulated control macrophages. 
Overlapping images show that stained cytoplasmic 15-d-PGJ2 and COX-1 matched perfectly with neutral lipid 
inclusions in CB-stimulated macrophages. Considering these results we investigated whether COX-1 contributes 
to formation of LDs induced by CB. As demonstrated in Fig. 8B, 1 h pretreatment of macrophages cultures with 
valeryl salicylate (450 μM) or SC-560 (0.5 μM), both specific COX-1 inhibitors, did not affect LDs formation 
induced by CB after 3 h of stimulation in comparison with control cells, pretreated with vehicle and stimulated 
Figure 5. PLD and iPLA2, but not PLC and cPLA2 are required for CB-induced LD formation. Peritoneal 
macrophages were incubated with the inhibitors U73122-1 µM (A), FIPI-1 µM (B), BEL-2 µM, FKGK11- 1 µM 
or Pyr-2-1 µM (C) for 30 min and then with CB (0.4 µM) for 3 h. LDs were quantified using light microscopy 
after osmium staining. Each bar represents the mean ± SEM of LDs/cell in 50 cells. Values represent 
means ± SEM for 3–5 animals. *p < 0.05 compared with RPMI/vehicle-stimulated cells; #p < 0.05 compared 
with vehicle treated/CB-stimulated cells.
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with CB, indicating that COX-1 isoform is not involved in formation of LDs induced by CB. In the present exper-
imental condition, this isoform is committed to 15-d-PGJ2 synthesis. Taken together these findings indicate that 
CB has the capability to induce the synthesis of a pro-resolving lipid mediator (15-d-PGJ2) and its compartimen-
talization, in association with the prostaglandin-forming enzyme COX-1, in LDs. These data indicate the role of 
LDs as a relevant site for the synthesis and accumulation of 15-d-PGJ2 in macrophages stimulated by CB.
Discussion
Group IIA secreted phospholipases A2 are enzymes whose proinflammatory properties have been well estab-
lished53, 54. However, CB, a group IIA sPLA2 isolated from Cdt snake venom, interferes with the development 
of the inflammatory response by blocking important stages in this process, such as leukocyte recruitment and 
macrophage activation4, 5. In the present study, the ability of this GIIA sPLA2 to directly stimulate formation 
of LDs in macrophages and the mechanisms involved in this phenomenon were demonstrated. This effect was 
time-dependent, had a very fast onset with a maximum at 12 h, and persisted up to the 24-hour time-point. 
These data agree with previous reports from our group showing that two proinflammatory secreted PLA2s from 
Bothrops snake venom are able to induce LD formation in isolated macrophages47, 48. These results are interest-
ing as formation of this organelle in leukocytes is generally associated with a variety of phlogistic stimuli13, 55, 56, 
including stimuli by proinflammatory group IIA sPLA2s47, 48. In addition, to our knowledge, this is the first study 
showing that LD formation can be induced by group IIA sPLA2 that does not induce an inflammatory response.
PLIN2 is a LD marker protein and plays an important role in LD assembly and foam cell formation18–20 by 
its properties to bind lipids with high affinity and increase the uptake of long chain fatty acids57. Several studies 
have shown that PLIN2 expression has been directly related to enhanced neutral lipid storage and biogenesis of 
LDs in a variety of cell types13, 21, 46, 47. Our results show that CB induces PLIN2 recruitment from its membrane 
pools, suggesting a role for this protein as a nucleation site for formation of new LDs under the stimulus by this 
sPLA2. Moreover, up-regulation of PLIN2 expression observed within 12 h of stimulation by CB suggests a mech-
anism for LD formation in CB-stimulated macrophages. These results differ from those obtained with MT-III, 
a pro-inflammatory PLA2 isolated from Bothrops snake venom, which induced an increase in PLIN2 protein 
expression in macrophages only 6 h after they were stimulated47.
Next, we investigated the mechanisms by which CB stimulates LD formation in macrophages by focusing on 
major downstream signaling protein kinases that have previously been shown to participate in LD biogenesis 
Figure 6. CB induces COX-1- and PGDS-dependent release of 15-d-PGJ2 from macrophages. Macrophages 
(1 × 106 cells) were incubated with CB (0.4 µM) or RPMI (control) for 1 up to 24 h. (A) Quantification of 15-d-
PGJ2 in culture supernatants by specific EIA. (B) Treatment of macrophages with valeryl salicylate (450 μM), 
SC-560 (0.5 μM) or HQL-79 (30 μM) for 1 h before stimulation with CB (0.4 µM) or RPMI (control) for 3 or 
12 h. 15-d-PGJ2 was quantified by specific EIA. Values represent means ± SEM from 3–4 experiments. *p < 0.05 
as compared with RPMI/vehicle-stimulated cells, +p < 0.05 and  &p < 0.05 as compared with vehicle treated/CB-
stimulated cells, and #p < 0.05 as compared with CB-stimulated cells for 1, 3, 6 and 24 h.
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induced by inflammatory and infectious stimuli. Our results revealed rapid activation of the signaling proteins 
PKC, PI3K, MEK1/2 and JNK, but not p38MAPK or ERK1/2, in macrophages activated by CB. While inhibition of 
PKC, PI3K, MEK1/2 and JNK abolished the CB-induced increase in LD formation, indicating that these signa-
ling proteins contribute to this increase, p38MAPK and ERK1/2 do not play a role in CB-induced LD formation. 
In light of these results, it is reasonable to suggest that PKC and PI3K are crucial in LD formation induced by 
venom sPLA2s since both proteins are involved in LD formation induced by both Crotalus (CB) and Bothrops 
sPLA2s (MT-III and MT-II)47, 48. Our finding that CB-induced LD formation requires activation of the PI3K 
pathway is in accordance with data in the literature showing that this signaling protein plays a key role in path-
ways that up-regulate proteins associated with lipid accumulation such as peroxisome proliferator-activated 
receptor-gamma (PPAR-γ) and PLIN258, 59. In this context, our finding that CB-induced LD formation in mac-
rophages is largely dependent on both the MEK1/2 and JNK pathways agrees with the literature, which indicates 
that MEK1/2 and JNK are important signaling proteins implicated in foam-cell formation60, 61.
The literature shows that group IIA sPLA2s interact with intracellular PLA2s in the biosynthesis of lipid medi-
ators from fatty acids6 and also that LD formation involves the activation of intracellular PLA2s, such as iPLA2 
and cPLA2, as well as other classes of intracellular phospholipases, including PLC and PLD47–50. Our finding that 
inhibition of iPLA2 by BEL and FKGK11 reduced CB-induced LD biogenesis indicates that this intracellular 
PLA2 contributes to the effect of CB. However, although cPLA2 has been reported to be relevant to LDs forma-
tion induced by diverse PAMPS stimuli and a snake venom inflammatory sPLA225, 47 this intracellular PLA2 does 
not participate in the genesis of LDs induced by CB in macrophages. A recent study showed the important role 
Figure 7. CB-induced cytoplasmic LDs compartmentalize 15-d-PGJ2. (A) Macrophages incubated with 
RPMI (control) or CB (0.4 µM) for 3 h were labeled for LDs (Nile Red) and for 15d-PGJ2 (anti-15-d-PGJ2 
antibody, Cayman Chemical). The merged image shows colocalization of 15-d-PGJ2 to LDs. The pictures are 
representative of three independent experiments. (B) Treatment of macrophages with PKC inhibitors H7 
(6 µM) or GF109203X (1 μM) or (C) with JNK inhibitors JNK inhibitor II (2 μM) or SP600125 (10 µM) for 1 h 
before stimulation with CB (0.4 µM) or RPMI (control) for 3 h. 15-d-PGJ2 was quantified by specific EIA. Values 
represent means ± SEM from 3–4 experiments. *p < 0.05 as compared with vehicle treated RPMI-stimulated 
cells, #p < 0.05 as compared with vehicle treated CB-stimulated cells.
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of iPLA2 in fatty acid metabolism and triacylglycerol formation62. Since CB induces the release of high levels of 
arachidonic acid in macrophages7, our data suggest that upon stimulation by CB this fatty acid contributes to the 
synthesis of triacylglycerol, which in turn is an important component of LDs. However, the mechanism by which 
CB activates iPLA2 is unknown and will be investigated in future studies by our group. Additionally, our data 
show that PLD, but not PLC, is an important step in the signaling pathways involved in the CB-induced effect. 
It has been shown that PLD acts on the membrane lipid phosphatidylcholine to produce the signal molecule 
phosphatidic acid (PA), which is a negatively charged phospholipid whose small headgroup promotes membrane 
curvature, allowing lipid accumulation at this local and facilitating the budding of LDs63. In addition, PA can be 
converted to bioactive lipids, such as diacylglycerol and lysophosphatidic acid64. Therefore, any or all of these 
mechanisms may act in conjunction to mediate LD formation. This is the first demonstration that a group IIA 
sPLA2 crosstalks with PLD, activating LD formation. This finding agrees with an earlier study which showed that 
activation of PLD2 was induced by a murine group IIA sPLA2, indicating that there is crosstalk between PLA2s 
and PLD65.
A previous study by our group showed that CB induces production of high levels of PGD2 by macrophages7. It 
is known that PGD2 can be chemically modified by non-enzymatic dehydration reactions, leading to production 
of the cyclopentenone prostaglandin 15-deoxy-Δ12, 14 PGJ2 (15-d-PGJ2), an important lipid mediator involved 
in the resolution phase of inflammation11, 12. In line with our previous findings, the results of the present study 
show that CB-stimulated macrophages release significant amounts of 15-d-PGJ2 at all the time points, in a process 
dependent on COX-1 pathway and the terminal PGDS. Furthermore, our data show that (i) CB-induced LDs 
compartmentalizes both COX-1 and 15-d-PGJ2 and (ii) CB-induced 15-d-PGJ2 is abrogated when LD formation 
Figure 8. CB-induced cytoplasmic LDs compartmentalize COX-1, but this enzyme is not involved in LDs 
formation. (A) Macrophages incubated with RPMI (control) or CB (0.4 µM) for 3 h were labeled for LDs (Nile 
Red) and for COX-1 (anti-COX-1 antibody, Cayman Chemical). The merged image shows colocalization 
of COX-1 to LDs. The pictures are representative of three independent experiments. (B) Treatment of 
macrophages with valeryl salicylate (450 μM) or SC-560 (0.5 μM) a COX-1 inhibitors for 1 h, before stimulation 
with CB (0.4 µM) for 3 h. LDs were counted using light microscopy after osmium staining. Each bar represents 
the mean ± SEM of the number of LDs/cell in 50 cells. Values represent means ± SEM for three to five animals. 
*p < 0.05 compared
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is inhibited by pretreatment of macrophages with inhibitors of PKC and JNK, upstream and downstream sig-
naling proteins, respectively, that were shown to inhibit LD formation induced by CB. In light of these data, 
and considering that COX-1, but not COX-2, is activated by CB in macrophages7, and as LDs are important 
organelles for eicosanoid synthesis66, 67, it is reasonable to suggest that CB-induced LDs are sites for 15-d-PGJ2 
synthesis via the COX-1 enzymatic system. To our knowledge, this is the first demonstration that LDs induced 
by a group IIA sPLA2 are equipped with a COX-1 enzymatic system and are involved in synthesis of a lipid 
mediator implicated in inflammatory resolution, such as 15-d-PGJ2. In addition, it should be noted that release 
of the anti-inflammatory mediator 15-d-PGJ2 is in line with the immunomodulatory effects of CB and sheds new 
light on the mechanisms by which whole Crotalus snake venom and CB, its major sPLA2, can reduce or abolish 
inflammatory events5, 68.
In conclusion, our data show that group IIA sPLA2 CB directly activates peritoneal macrophages to form LDs 
by a mechanism that is dependent on increased expression and distribution of PLIN2 and requires activation of 
PKC, PI3K, MEK1/2 and JNK. We also showed that this venom sPLA2 crosstalks with iPLA2 and PLD to induce 
LDs formation. Our results also indicate for the first time that LDs can constitute platforms implicated in the syn-
thesis of anti-inflammatory lipid mediators such as 15-d-PGJ2 in macrophages stimulated by a sPLA2. Therefore, 
the LDs, classicaly recognized as relevant organelles of the acute phase of inflammation, can be involved in both 
development and resolution of the inflammatory process. Finally, our results reinforce previous findings that 
phospholipases A2 from snake venom can induce LDs formation in immunocompetent cells and afford new 
insights into the roles of LDs in the inflammatory process.
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